Vose JM - Search Results

1

Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission.

Landsburg DJ, Falkiewicz MK, Maly J, Blum KA, Howlett C, Feldman T, Mato AR, Hill BT, Li S, Medeiros LJ, Torka P, Hernandez-Ilizaliturri F, Reddy NM, Singavi A, Fenske TS, Chavez JC, Kaplan JB, Behdad A, Petrich AM, Bast MA, Vose JM, Olszewski AJ, Costa C, Lansigan F, Gerson JN, Barta SK, Calzada O, Cohen JB, Lue JK, Amengual JE, Rivera X, Persky DO, Peace DJ, Nathan S, Cassaday RD. Landsburg DJ, et al. Among authors: vose jm. J Clin Oncol. 2017 Jul 10;35(20):2260-2267. doi: 10.1200/JCO.2017.72.2157. Epub 2017 May 5. J Clin Oncol. 2017. PMID: 28475457 Free PMC article.

2

Central nervous system involvement in patients with diffuse aggressive non-Hodgkin's lymphoma.

Bashir RM, Bierman PJ, Vose JM, Weisenburger DD, Armitage JO. Bashir RM, et al. Among authors: vose jm. Am J Clin Oncol. 1991 Dec;14(6):478-82. doi: 10.1097/00000421-199112000-00004. Am J Clin Oncol. 1991. PMID: 1720278

3

Histologic grade does not predict prognosis in optimally treated, advanced-stage nodular sclerosing Hodgkin's disease.

Masih AS, Weisenburger DD, Vose JM, Bast MA, Armitage JO. Masih AS, et al. Among authors: vose jm. Cancer. 1992 Jan 1;69(1):228-32. doi: 10.1002/1097-0142(19920101)69:1<228::aid-cncr2820690137>3.0.co;2-9. Cancer. 1992. PMID: 1727667

4

Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease.

Armitage JO, Bierman PJ, Vose JM, Anderson JR, Weisenburger DD, Kessinger A, Reed EC, Vaughan WP, Coccia PF, Purtilo DT. Armitage JO, et al. Among authors: vose jm. Am J Med. 1991 Dec;91(6):605-11. doi: 10.1016/0002-9343(91)90213-h. Am J Med. 1991. PMID: 1750430

5

Diffuse "histiocytic" lymphoma.

Vose JM, Armitage JO. Vose JM, et al. Semin Oncol. 1991 Feb;18(1):50-60. Semin Oncol. 1991. PMID: 1992524 Review. No abstract available.

6

CHLVPP chemotherapy with involved-field irradiation for Hodgkin's disease: favorable results with acceptable toxicity.

Vose JM, Bierman PJ, Anderson JR, Weisenburger D, Moravec DF, Sorensen S, Hutchins M, Dowling MD, Howe D, Okerbloom J, et al. Vose JM, et al. J Clin Oncol. 1991 Aug;9(8):1421-5. doi: 10.1200/JCO.1991.9.8.1421. J Clin Oncol. 1991. PMID: 2072145

7

Salvage therapy for patients with non-Hodgkin's lymphoma.

Armitage JO, Vose JM, Bierman PJ. Armitage JO, et al. Among authors: vose jm. J Natl Cancer Inst Monogr. 1990;(10):39-43. J Natl Cancer Inst Monogr. 1990. PMID: 2189475 Review.

8

The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma.

Vose JM, Armitage JO, Weisenburger DD, Bierman PJ, Sorensen S, Hutchins M, Moravec DF, Howe D, Dowling MD, Mailliard J, et al. Vose JM, et al. J Clin Oncol. 1988 Dec;6(12):1838-44. doi: 10.1200/JCO.1988.6.12.1838. J Clin Oncol. 1988. PMID: 2462026

9

Clinical significance of immunophenotype in diffuse aggressive non-Hodgkin's lymphoma.

Armitage JO, Vose JM, Linder J, Weisenburger D, Harrington D, Casey J, Bierman P, Sorensen S, Hutchins M, Moravec DF, et al. Armitage JO, et al. Among authors: vose jm. J Clin Oncol. 1989 Dec;7(12):1783-90. doi: 10.1200/JCO.1989.7.12.1783. J Clin Oncol. 1989. PMID: 2585020

10

Salvage therapy for relapsed or refractory non-Hodgkin's lymphoma utilizing autologous bone marrow transplantation.

Vose JM, Armitage JO, Bierman PJ, Weisenburger DD, Hutchins M, Dowling MD, Moravec DF, Sorensen S, Okerbloom J, Bascom G, et al. Vose JM, et al. Am J Med. 1989 Sep;87(3):285-8. doi: 10.1016/s0002-9343(89)80152-4. Am J Med. 1989. PMID: 2672808

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

517 results

Search Page